D-0130-2020 Class II Terminated

Recalled by Morton Grove Pharmaceuticals, Inc. — Morton Grove, IL

FDA drug recall D-0130-2020 was initiated by Morton Grove Pharmaceuticals, Inc. on Sep 23, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications - failed specs for Prednisolone Impurity 14 The recall status is terminated (terminated Sep 24, 2022). Affected quantity: 196,408 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 16, 2019
Initiation Date
Sep 23, 2019
Termination Date
Sep 24, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
196,408 bottles

Product description

Prednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, packaged in a 8 fl oz (237 mL) bottle, Rx only, Manufactured By Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053. NDC 60432-212-08

Reason for recall

Failed Impurities/Degradation Specifications - failed specs for Prednisolone Impurity 14

Distribution pattern

Nationwide USA and Puerto Rico

Code information

Lot #: US1450, Exp 10/31/19; US1570, Exp 12/31/19; UT1018, Exp 1/31/19; UT1173, Exp 6/30/20; UT1348, UT1354, Exp 8/31/20

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0130-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0130-2020. Report a data issue: hello@regdatalab.com.